GCG and type 2 diabetes mellitus: There is growing appreciation that a considerable portion of the glucose-lowering effect of GLP-1 is underscored by its inhibitory effect on gastric motility (80–83) and its glucagonostatic action (84, 85), which are preserved in obese and T2D patients (86, 87).